Korean non-life premiums to grow 4.4% to US$94bn in 2023: Korean Re
September 26 2023 by InsuranceAsia News
-
South Korea’s non-life insurance outlook stable on new regulations, strong P&C, motor results: AM Best
- November 15
In terms of challenges faced by the segment, AM Best highlighted slower expansion of auto insurance owing to recent rate cuts and sluggish growth in motor vehicle registrations as a key factor.
-
Envest acquires majority stake in Bendigo Insurance Brokers
- November 14
The merger will add the broker to the network of Aviso Group and will bring the combined GWP up to US$616.4bn with the addition of the broker's US$13.3mn of gross written premium.
-
Amit Ganorkar returns to Tata AIG as managing director and CEO
- November 12
Ganorkar, who was previously the chief operating officer of the Indian insurer, takes over from Neelesh Garg, who resigned last month.
-
AIG Korea takes Aon’s Han Bit Kim as financial lines underwriter
- November 12
Seoul-based Kim was most recently manager for the broker focused on the dynamics of large complex insurance policies.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
